皮肤病学中的生物类药物审查
1Dermatology Department, University at Buffalo, Buffalo, NY, USA.
Journal of psoriasis and psoriatic arthritis
|September 20, 2024
概括
生物仿制药可大大节省成本,并增加了获得有价值药物的机会. 医生教育和处方激励措施是实现美国生物类似药益处的关键,美国的市场份额仍在增长.
科学领域:
- 皮肤病学 皮肤病学
- 药物经济学 药物经济学
- 药物开发 药物开发
背景情况:
- 生物类似药物,如infliximab和rituximab,已获得FDA批准,并且在皮肤病学中越来越多.
- 在2023年即将出现的阿达利穆马布生物类似药的可用性意味着越来越多的兴趣和潜在的市场扩张.
- 生物仿制药旨在提高患者获得基本生物疗法的机会.
研究的目的:
- 审查生物类似的基础知识及其在美国,亚洲和欧洲的皮肤病学中的利用.
- 分析生物类似药在全球不同地区的经济影响和市场透率.
- 确定影响生物仿制药在临床实践中成功应用的因素.
主要方法:
- 关于Ovid/Medline (2015-2023) 的生物类似文章的综合文献综述,重点是皮肤病学.
- 包括行业报告和博客,以获取对生物类似药市场格局的见解.
- 分析区域经验,特别是在欧洲和美国,关于生物类似药的采用和节省.
主要成果:
- 生物类药物已经证明了大幅节省成本和市场份额的增长,特别是在欧洲,由于市场经验较长.
- 储蓄和市场份额的程度因国家而异,受规定习惯和财务激励的影响.
- 目前在美国的生物类似药尚未达到欧洲的节约和市场透水平.
结论:
- 生物仿制药可以实现显著的成本节约,但医生教育和处方激励措施对于最大限度地发挥这些益处至关重要.
- 生物类似药在美国的未来市场份额仍然不确定,将取决于政策和医生的采用.
- 优化生物仿制药的利用需要采取多方面的方法,既应对医疗保健提供者教育,又应对经济驱动因素.
相关概念视频
Bioequivalence: Overview
942
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
942
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
Skin Diseases and Disorders
3.7K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.7K


